InsidersTradesSigma
Follow the Telomir Pharmaceuticals, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €74.3m. The latest transaction was filed on 24 April 2026 (J). Among the most active insiders: Aminov Erez. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Telomir Pharmaceuticals, Inc. 是一家专注于开发基于端粒生物学的创新疗法的制药公司。该公司在纳斯达克上市，股票代码为XNAS。